COMMUNIQUÉS West-GlobeNewswire

Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors
08/04/2025
Las Vegas, Nevada, April 07, 2025 (GLOBE NEWSWIRE) -- Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that John P. Hopkins has been appointed Executive Chairman of the Company’s Board of Directors, [...]
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
07/04/2025
ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve [...]
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
07/04/2025
SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial [...]
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/04/2025
BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis (“OA”) Pain Management and Regenerative Solutions space focused on early intervention [...]
Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
07/04/2025
Auditor Licensing & Personnel Issues Delays Issuance of Audit Opinion The Company expects to file within 1 week TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) ( [...]
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
07/04/2025
SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that Chief [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07/04/2025
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 07 avr. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Monthly information on share capital and company voting rights
07/04/2025
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, April 07, 2025 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL
07/04/2025
-- Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a confidential date in 2030 -- -- Fresenius also licensed to sell generic [...]
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
07/04/2025
PITTSBURGH, April 07, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal’s clinically validated gene-delivery [...]
CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)
07/04/2025
NEW HYDE PARK, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CareMed, an independent specialty pharmacy, is in the Limited Distribution Network for Vanrafia ™ (atrasentan), for the reduction of proteinuria in adults with [...]
Solésence Announces Uplisting to Nasdaq
07/04/2025
Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and [...]
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
07/04/2025
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic [...]
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
07/04/2025
CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
CVRx Reports Preliminary First Quarter 2025 Financial Results
07/04/2025
First quarter revenue expected to be approximately $12.3 million, representing growth of approximately 15% over first quarter 2024 MINNEAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a [...]
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
07/04/2025
Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience WILMINGTON, Del., April 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover [...]
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
07/04/2025
WARREN, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, is unified [...]
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
07/04/2025
BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close [...]
MESA LABS DECLARES QUARTERLY DIVIDEND
07/04/2025
LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $ [...]

Pages